{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:25:54Z","timestamp":1782602754975,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.jaad.2008.04.034","type":"journal-article","created":{"date-parts":[[2008,6,21]],"date-time":"2008-06-21T04:22:32Z","timestamp":1214022152000},"page":"654-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis"],"prefix":"10.1016","volume":"59","author":[{"given":"Yuval","family":"Bibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2008.04.034_bib1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V96.3.925","article-title":"Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor","volume":"96","author":"Heinrich","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2008.04.034_bib3","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1182\/blood-2004-07-2527","article-title":"Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner","volume":"105","author":"Seggewiss","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2008.04.034_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2008.04.034_bib5","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1517\/13543784.16.10.1549","article-title":"Future options for imatinib mesilate-resistant tumors","volume":"16","author":"Sankhala","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.jaad.2008.04.034_bib6","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.2003.11.143","article-title":"Practical management of patients with chronic myeloid leukemia receiving imatinib","volume":"21","author":"Deininger","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2008.04.034_bib7","first-page":"9","article-title":"Case report: rapid and complete control of idiopathic hypereosinophilia with imatinib mesylate","volume":"3","author":"Schaller","year":"2001","journal-title":"MedGenMed"},{"key":"10.1016\/j.jaad.2008.04.034_bib8","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0145-2126(02)00046-2","article-title":"Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate","volume":"26","author":"Ault","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2008.04.034_bib9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(02)08505-7","article-title":"Treatment of hypereosinophilic syndrome with imatinib mesilate","volume":"359","author":"Gleich","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2008.04.034_bib10","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2002-10-3103","article-title":"Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders","volume":"101","author":"Pardanani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2008.04.034_bib11","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib12","first-page":"236","article-title":"Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome","volume":"89","author":"Martinelli","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2008.04.034_bib13","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1182\/blood-2004-03-0787","article-title":"FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia","volume":"104","author":"Pardanani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2008.04.034_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3324\/haematol.11420","article-title":"The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome: results of a multicenter prospective study","volume":"92","author":"Baccarani","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jaad.2008.04.034_bib15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2008.04.034_bib16","first-page":"S59","article-title":"What did we learn by studying scleroderma fibroblasts?","volume":"22","author":"Trojanowska","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2008.04.034_bib17","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/art.1780331011","article-title":"Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis","volume":"33","author":"Klareskog","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.04.034_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1084\/jem.175.5.1227","article-title":"Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts","volume":"175","author":"Yamakage","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0923-1811(98)00027-9","article-title":"Expression of platelet-derived growth factor B-chain and platelet-derived growth factor beta-receptor in fibroblasts of scleroderma","volume":"18","author":"Zheng","year":"1998","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2008.04.034_bib20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.autrev.2006.06.001","article-title":"Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis","volume":"5","author":"Verrecchia","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2008.04.034_bib21","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1182\/blood-2007-01-071043","article-title":"Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease","volume":"110","author":"Svegliati","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaad.2008.04.034_bib23","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1002\/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1","article-title":"Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway","volume":"44","author":"Sambo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.04.034_bib24","doi-asserted-by":"crossref","first-page":"36474","DOI":"10.1074\/jbc.M502851200","article-title":"Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK1\/2: amplification of ROS and Ras in systemic sclerosis fibroblasts","volume":"280","author":"Svegliati","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2008.04.034_bib25","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1056\/NEJMc061927","article-title":"Stimulatory autoantibodies to the PDGF receptor in scleroderma","volume":"355","author":"Lozano","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.20041393","article-title":"Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis","volume":"201","author":"Abdollahi","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib27","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200404-531OC","article-title":"Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice","volume":"171","author":"Aono","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/01902140701634827","article-title":"Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia","volume":"33","author":"Vuorinen","year":"2007","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.jaad.2008.04.034_bib29","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMc051946","article-title":"Imatinib for the treatment of pulmonary arterial hypertension","volume":"353","author":"Ghofrani","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2008.04.034_bib30","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1172\/JCI24838","article-title":"Reversal of experimental pulmonary hypertension by PDGF inhibition","volume":"115","author":"Schermuly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2008.04.034_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s004410050009","article-title":"PDGF receptor kinase blocker AG1295 attenuates interstitial fibrosis in rat kidney after unilateral obstruction","volume":"299","author":"Ludewig","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jaad.2008.04.034_bib32","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/01.HYP.0000202487.68969.f7","article-title":"Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats","volume":"47","author":"Schellings","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jaad.2008.04.034_bib33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/01.RES.0000190590.31545.d4","article-title":"Platelet-derived growth factor D induces cardiac fibrosis and proliferation of vascular smooth muscle cells in heart-specific transgenic mice","volume":"97","author":"Ponten","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jaad.2008.04.034_bib34","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"Distler","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.04.034_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0889-857X(21)01038-3","article-title":"Early detection of connective tissue disease in patients with Raynaud's phenomenon","volume":"16","author":"Kallenberg","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaad.2008.04.034_bib36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1","article-title":"Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis","volume":"42","author":"Rajkumar","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.04.034_bib37","first-page":"2263","article-title":"Effect of temperature and modulators of protein tyrosine kinase activity on the reactivity of isolated venules in secondary Raynaud's phenomenon","volume":"28","author":"Furspan","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2008.04.034_bib38","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/art.20214","article-title":"Increased tyrosine phosphorylation mediates the cooling-induced contraction and increased vascular reactivity of Raynaud's disease","volume":"50","author":"Furspan","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.04.034_bib39","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/1529-0131(200005)43:5<1068::AID-ANR17>3.0.CO;2-G","article-title":"Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association","volume":"43","author":"Zhou","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2008.04.034_bib40","unstructured":"US National Institutes of Health. ClinicalTrials.gov. Available at: http:\/\/www.clinicaltrials.gov. Accessed May 27, 2008"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208005987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962208005987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:10:54Z","timestamp":1759270254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962208005987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0190962208005987"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2008.04.034","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2008.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}